An interventional study of Group A, who will complete a questionnaire before receiving information about intrauterine devices and Group B who will answer a questionnaire after having the information about the intrauterine devices in Acceptance Processes, sponsored by Raincy Montfermeil Hospital Group. Status unknown at 1 site in France. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2022-05-02.
Sponsored by Raincy Montfermeil Hospital Group · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Behavior with a site in France — 15 open to participants now, 15 under way, none of them phase 3. Behavior · France.
Among the 69 studies in Behavior with a site in France, this one is the 14th largest by planned enrollment of the 47 interventional ones that give a count, is one of 5 that started in 2022, is one of 45 with no phase, and was the 49th registered.
1,579 studies on the registry are indexed under Behavior; 314 are open to participants now.
Browse Behavior studies →15 of the 69 studies in Behavior with a site in France are open now. Recruiting first, the newest first:
Centre Hospitalier de Martigues · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 20–80 · Healthy volunteers
LNA SANTE · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Besancon · Sites in France
Ages 18–65 · Healthy volunteers
University of Bordeaux · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 177 Behavior studies recruiting now, 77 (44%) set no upper age limit and 72 (41%) stop at 75 or younger; 58 take children under 18; 99 take healthy volunteers.
This study: 18 Years to 45 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 5 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 160 is above the median of 120 across 1,202 interventional studies indexed under Behavior.
Median enrollment 100 across the 47 interventional studies, 112 across the 22 observational. Of the 43 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 69 have an industry lead sponsor. The 10 most frequent:
Raincy Montfermeil Hospital Group is the lead sponsor of 8 studies on the registry; 1 is open to participants now.
Raincy Montfermeil Hospital Group has 1 study filed under Behavior — fewer than ten, so there is no comparison to draw.
2 of the studies in Behavior with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04638452Centre Hospitalier Charles Perrens, BordeauxEvaluation of Behavioural Psycho & Physiological Responses in People With ASD During a Blood Test in Routine Care Practice | 2026-11-30 |
| NCT07730957LNA SANTEProtocolized Receptive Music Intervention to Reduce Care Refusal in Nursing Home Residents With Major Neurocognitive Disorders | 2027-06-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 69 studies in Behavior with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.
Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.
In practice, in France, use of the IUD is still "reserved" for older women or those who have already had children, despite medical recommendations.
In this study the investigator will investigate whether clear information about the mode of action and insertion/withdrawal of IUDs would dispel these misconceptions of patients.
Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.
Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.
In practice in France, the use of IUDs is still "reserved" for older women or those who have already had children, despite medical recommendations. Indeed, there is a certain feeling of mistrust towards the IUD as a contraceptive method. Sometimes the patient's reasons for refusal were unclear or misconceptions and prejudices prevailed.
Various research studies and theses have identified the various obstacles to the use of the IUD as a contraceptive. Today it would be interesting to evaluate whether a short presentation of the IUD during a consultation would lead to a better acceptance of women to use it as a possible contraceptive method.
In this study the investigators will investigate whether clear information about the mode of action and insertion/removal of IUDs would dispel these misconceptions of patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
this group of patients will complete a questionnaire before receiving information on contraceptive intrauterine devices (copper or hormonal)
Other: Group A, who will complete a questionnaire before receiving information about intrauterine devices
This group of patients will receive information about contraceptive intrauterine devices (copper or hormonal) before completing a questionnaire
Other: Group B who will answer a questionnaire after having the information about the intrauterine devices
Group A will complete a questionnaire before receiving information about intrauterine devices and a demonstration of insertion/removal on a plastic dummy uterus.
Group B will complete a questionnaire after receiving information about IUDs and a demonstration of insertion/removal on a plastic dummy uterus.
Rate of acceptance of the IUD as a possible contraceptive method
measuring the acceptance rate of the intrauterine device as a potential contraceptive method
Time frame: day 1
Basic knowledge of intrauterine devices
verification of Basic knowledge of intrauterine devices
Time frame: day 1
Plan to share: No
Started Apr 2022 (actual). Primary completion is estimated for Aug 2022, 4 months after the start.
Of 745 non-industry interventional studies with no phase under Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 32. This study's planned 4 months is below that.
Counting every sponsor, half of 761 studies reached it within 13 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Raincy Montfermeil Hospital Group